1-4 of 4
Byoung K. Kim, MD PhD
Close
Sort by
Journal Articles

Novel Synthetic Histone Deacetylase Inhibitor, SK-7041, Has Potent Anti-Proliferative Activity in Acute Myeloid Leukemia Cell Lines.

Sung-Soo Yoon, MD, PhD, Eunkyung Bae, MS, Juwon Park, MS, Yongjun Cha, MD, Young Y. Lee, MD, PhD, Byoung K. Kim, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2854.
https://doi.org/10.1182/blood.V110.11.2854.2854
Published: 2007
Journal Articles

Soluble IL-6 Receptor Synergistically Stimulates the Growth of Multiple Myeloma with IL-6 and Confers Resistance to Bortezomib.

Young Y. Lee, MD, PhD, Joowon Park, MS, Sung-Soo Yoon, MD PhD, Jung H. Choi, MD PhD, Byoung B. Park, MD, Byoung K. Kim, MD PhD
Journal: Blood
Blood (2007) 110 (11): 4741.
https://doi.org/10.1182/blood.V110.11.4741.4741
Published: 2007
Journal Articles

FLT3 Is Up-Regulated in Blast Crisis of Chronic Myeloid Leukemia and Combination of Small Interference RNA of FLT3 and Gleevec (STI571) Synergistically Induces the Apoptosis in K562 Cells.

Young Y. Lee, MD, PhD, Kwang-Sung Ahn, PhD, Sung-Soo Yoon, MD PhD, Jung H. Choi, MD PhD, Byoung B. Park, MD, Byoung K. Kim, MD PhD
Journal: Blood
Blood (2007) 110 (11): 4532.
https://doi.org/10.1182/blood.V110.11.4532.4532
Published: 2007
Journal Articles

Combined Treatment of STI571 (Glivec) and Curcumin Synergistically Suppresses the Growth of K562 Cells Via Inhibition of Bcr-Abl Pathway.

Juwon Park, MS, Eunkyung Bae, MS, Sung-Soo Yoon, MD, PhD, Byoung K. Kim, MD PhD
Journal: Blood
Blood (2007) 110 (11): 4537.
https://doi.org/10.1182/blood.V110.11.4537.4537
Published: 2007